Northside Hospital, Inc.

This study tests whether changing when spinal fluid chemotherapy is given can reduce brain-related side effects during blinatumomab treatment for acute lymphoblastic leukemia. Researchers will give the preventive chemotherapy before and during the main treatment to see if it prot…

This study is testing whether a drug called sargramostim can help patients recover their immune systems faster and with fewer infections after a stem cell transplant for blood cancer. The transplant uses cells from a partially matched family donor. Researchers will compare this d…

This study is testing if giving an immunosuppressant drug called tacrolimus earlier in the stem cell transplant process can safely reduce a dangerous immune overreaction called Cytokine Release Syndrome (CRS). It involves 20 patients with blood cancers who are receiving a transpl…

This study is testing whether a powerful cancer treatment called CAR-T therapy can be safely given to people with moderate to severe kidney problems. Researchers are adjusting the dose of the chemotherapy drugs given right before the CAR-T cells to see if it reduces serious side …

This study tests a bone marrow transplant method for people with severe aplastic anemia who don't have perfectly matched family donors. Researchers are using partially matched family donors along with specific medications after transplant to help the body accept the new cells. Th…

This trial is testing a modified bone marrow transplant procedure for people with blood cancers. It's designed for patients who need a transplant but only have a partially matched family donor. The study will see if using a lower-intensity preparation treatment before the transpl…

This study is testing a two-drug combination (belumosudil and rituximab) as the first treatment for people who develop extensive chronic graft-versus-host disease after a bone marrow transplant. The trial will enroll 25 patients who haven't received previous treatment for this co…